Regulating CAR T Cells: A Remote Control Approach

Area of Science:

• Biotechnology
• Immunotherapy
• Organic Chemistry

Background:

• Chimeric antigen receptor (CAR) T cell therapy is a promising cancer treatment.
• Current CAR T cell engineering requires specific receptors for each tumor antigen, limiting scalability.

Purpose of the Study:

• To develop a universal adaptor molecule for CAR T cell therapy.
• To enable FITC-binding CAR T cells to target tumors expressing specific antigens.

Main Methods:

• Synthesis of small organic molecules (adaptors) with a tumor-specific ligand and FITC.
• Utilizing adaptors to bridge FITC-binding CAR T cells and tumor cells.

Main Results:

• Successfully synthesized adaptor molecules with dual functionality.
• Demonstrated the ability of adaptors to facilitate CAR T cell-tumor cell bridging.

Conclusions:

• Adaptor molecules offer a versatile approach to CAR T cell therapy.
• This strategy simplifies the engineering process and broadens the applicability of CAR T cells in cancer treatment.